Global Leading Market Research Publisher QYResearch announces the release of its latest report "Functional Gummies - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032". Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Functional Gummies market, including market size, share, demand, industry development status, and forecasts for the next few years. The global market for Functional Gummies was estimated to be worth USD 1,549 million in 2024 and is forecast to a readjusted size of USD 2,688 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031. Functional gummies, also called Nutraceutical Gummies, are one of the fastest growing nutraceutical segments across Europe, North America and Asia. It usually contains various vitamin, DHA, Omega-3, Probiotics, minerals and other functionalities actives. Functional gummies have wide range of applications, such as vitamin and minerals gummies, DHA and Omega-3 Gummies, Probiotics Gummies, Plant Extract Gummies, etc. And vitamin and minerals gummy was the most widely used area which took up about 63.04% of the global total market size. Church & Dwight (CHD), SCN BestCo, Sirio Pharma, Amapharm, Guangdong Yichao, Aland, Herbaland, Jinjiang Qifeng, TopGum, PharmaCare, etc. are the key suppliers in the global functional gummies market. Top 10 took up more than 60% of the global market. The process of producing functional gummies using starch molds is a traditional process. The starch in this process can be recycled and dust in the production workshop needs to be controlled, so although this process is well suited for large-scale production, starch-free processes have become more popular in the market in recent years. 【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】 https://www.qyresearch.com/reports/4736858/functional-gummies 1. Executive Summary: Addressing the Core Pain Points of Traditional Supplement Delivery For CEOs of nutraceutical brands, consumer packaged goods companies, and healthcare investors, a persistent and growing challenge is the consumer rejection of traditional supplement formats – large, hard-to-swallow tablets (choking risk for elderly and children), unpleasant-tasting capsules (fish oil burps), and messy powders (inconvenient, inaccurate dosing). This leads to poor adherence: studies published in the Journal of Dietary Supplements (2024) indicate that 40-50% of consumers who purchase traditional vitamins or omega-3 products do not finish the bottle, citing unpleasant consumption experience. Additionally, the shift in consumer preference toward "treatable wellness" – where consumers want supplements that feel like candy but deliver genuine health benefits – has created an enormous market gap that traditional formats cannot fill. The proven solution is functional gummies (also known as nutraceutical gummies) – chewable, gelatin- or pectin-based confectionery that incorporate vitamins, minerals, DHA and omega-3 fatty acids, probiotics, plant extracts (turmeric, elderberry, ashwagandha), and other bioactive ingredients. These products deliver the sensory pleasure of candy combined with the health benefits of supplements. Unlike tablets which require swallowing, gummies offer superior compliance (consumer adherence rates of 80-90% compared to 50-60% for tablets), effective masking of unpleasant tastes (particularly for fish oil, iron, zinc, and bitter herbal extracts), precise dosing (each gummy contains a standardized amount of active ingredients), and excellent portability (no water needed for consumption). For manufacturers, functional gummies command higher price points – typically 1.5 to 2.5 times the daily dose cost compared to traditional tablets – while generating stronger brand loyalty, as flavor, texture, and the "treat" positioning drive consistent repeat purchase behavior. According to exclusive QYResearch data, the global functional gummies market was valued at USD 1,549 million in 2024 and is projected to reach USD 2,688 million by 2031, registering a robust 8.2% CAGR. This growth is driven by three accelerating forces: increased health-consciousness following the COVID-19 pandemic (immune support gummy sales grew 35% during 2021-2022 and have sustained over 10% annual growth through 2024), aging populations seeking convenient supplementation (elderly consumers, particularly those with dysphagia or difficulty swallowing, strongly prefer gummies over tablets), and continuous innovation in vegan and plant-based formulations (addressing consumer aversion to gelatin and growing demand for sustainably sourced ingredients). Functional gummies span five major application categories. Vitamin and mineral gummies remain the dominant segment, accounting for approximately 63.04% of the global market. This category includes daily immune support products (vitamin C, vitamin D, zinc), prenatal nutrition (folic acid and iron–though iron presents significant taste-masking challenges), bone health formulations (calcium combined with vitamin D3), and children's complete multivitamins, where the gummy format has become the preferred delivery method for ages two through twelve. The DHA and omega-3 gummies segment, representing approximately 12% of the market, addresses brain health (particularly for children requiring focus support and dyslexia-related supplementation), prenatal nutrition (DHA for fetal brain development, with gummies preferred over softgels by pregnant women experiencing nausea), heart health for older adults (offering fish oil without the unpleasant aftertaste or burping), and plant-based DHA from algae for vegan consumers. Probiotics gummies, at approximately 10% of the market, support gut health, immune function, and women's health (urinary tract and vaginal microbiome maintenance). Plant extract gummies, the fastest-growing segment at approximately 8% of the market, include turmeric and curcumin for inflammation and joint health (bioavailability enhanced with piperine or phytosome technology), elderberry for immune support, and ashwagandha for stress reduction, cortisol management, and sleep improvement. Other gummies, representing approximately 7% of the market, encompass collagen for beauty and skin health, melatonin for sleep aid, and mushroom-based formulations (lion's mane for cognitive function, reishi for stress management, cordyceps for energy support). Church & Dwight (CHD), SCN BestCo, Sirio Pharma, Amapharm, Guangdong Yichao, Aland, Herbaland, Jinjiang Qifeng, TopGum, PharmaCare, and others are the key suppliers in the global functional gummies market. The top 10 manufacturers together account for more than 60% of the global market. The traditional process of producing functional gummies uses starch molds – where starch can be recycled and dust in the production workshop must be strictly controlled. While this traditional process is well-suited for large-scale production, starch-free (also called starchless or mogul-less) processes have become increasingly popular in the market in recent years due to faster changeover times, reduced dust control requirements, and the ability to produce smaller batches for premium and novel formulations. 2. Product Definition & Technology Landscape: From Confectionery to Nutraceutical Delivery A functional gummy is a starch-free or starch-molded confectionery matrix containing suspended or emulsified bioactive ingredients. The base formulation typically consists of sweeteners (sugar, glucose syrup, allulose, or stevia for reduced-sugar products), gelling agents (gelatin for traditional texture; pectin, agar, carrageenan, or tapioca starch for vegan formulations), acidulants (citric, malic, or lactic acid to provide tartness and ensure shelf stability), natural or artificial flavors (specifically selected to mask the taste of active ingredients), colors (ranging from fruit and vegetable juices to FD&C certified colorants), and the functional active components. Key formulation challenges include maintaining active ingredient stability under processing temperatures and pH conditions, effective taste masking particularly for iron, DHA, EPA, and herbal extracts, and ensuring texture compatibility since certain active ingredients can interfere with the gelation process. Based on QYResearch's segmentation, the market is divided by gelling agent base, a critical attribute that determines target consumer demographics and permissible product claims. Gelatin-based functional gummies historically dominate the market, accounting for approximately 65% to 70% of 2024 revenue, roughly USD 1,007 million to USD 1,084 million, with a projected CAGR of 7.0%. These products derive their gelling properties from porcine or bovine collagen. The advantages of gelatin include superior texture (chewy and elastic, providing the familiar "gummy candy" mouthfeel that consumers expect), lower ingredient cost (gelatin is typically 20% to 30% less expensive than high-quality pectin), and better heat stability (gelatin can be deposited at higher temperatures, allowing faster production line speeds). The disadvantages are equally significant: gelatin-based gummies are not suitable for vegetarian or vegan consumers, who represent an estimated 15% to 20% of nutraceutical buyers that avoid gelatin for religious or ethical reasons. Additionally, halal and kosher certification is required for market access in the Middle East, Israel, and parts of Asia. These products are primarily used in mainstream functional gummy applications such as vitamin C, multivitamins, calcium, and vitamin D3, sold through mass retail channels including Walmart, Target, Costco, CVS, and Walgreens. Leading gelatin gummy manufacturers include Church & Dwight (whose Vitafusion brand is the number one functional gummy in North America), SCN BestCo (a contract manufacturer serving major brands), PharmaCare, Robinson Pharma, and Hero Nutritionals (known for the Yummi Bears children's gummy vitamin line). Vegan and pectin-based functional gummies represent the fastest-growing segment, accounting for approximately 30% to 35% of 2024 revenue, roughly USD 465 million to USD 542 million, with a projected CAGR of 10.5%. These products use plant-based gelling agents including pectin derived from citrus or apple, agar from seaweed, carrageenan from red seaweed, or tapioca starch. The advantages are compelling for manufacturers targeting specific consumer segments: these gummies appeal to vegetarian, vegan, and plant-forward consumers; they are kosher (parave) and halal certified by default since they contain no animal ingredients; and they support "clean label" positioning, as pectin is perceived as natural compared to gelatin derived from processed animal hides. The disadvantages include more complex formulation requirements, as pectin requires precise pH control (typically between 3.2 and 3.6) for stable gelation; a narrower processing window, requiring deposition at lower temperatures below 82°C compared to 90°C or higher for gelatin, which slows line speeds; higher ingredient costs, with premium pectin priced at USD 8 to USD 12 per kilogram versus USD 4 to USD 7 per kilogram for gelatin; and less compatibility with active ingredients that alter pH or compete for water in the formulation. These products are used in premium brands targeting health-conscious, eco-conscious, and ethically motivated consumers, as well as in the European market where gelatin alternatives are strongly preferred. They are also the platform of choice for DHA and omega-3 gummy formulations that avoid fish-derived gelatin by using algae-derived DHA with pectin base to create fully plant-based omega-3 gummies. Leading vegan and pectin gummy manufacturers include Sirio Pharma (a China-based global contract manufacturer with strong plant-based turnkey capabilities), Amapharm (Germany), Aland (a Chinese manufacturer specializing in pectin-based gummies for export to halal markets), Herbaland (a Canadian producer of vegan and sugar-free functional gummies selling through direct-to-consumer and wholesale channels), TopGum (an Israeli company with patent-pending pectin-based technology for low-sugar, high-active-load gummies), Guangdong Yichao (a large-scale Chinese vegan gummy exporter), Ningbo Jildan (China), Catalent through its Bettera Wellness division (producing premium pectin gummies for nutraceutical brands), Procaps (through its Funtrition brand), Cosmax (Korea), and MeriCal. Industry Analyst's Note: A significant innovation observed during 2024 and 2025 is the high-load active gummy, achieved through modified starch-pectin blends that incorporate three to five times higher concentrations of bioactive ingredients compared to standard gummies. Examples include up to 500 milligrams of vitamin C per single gummy compared to the standard 50 to 100 milligrams, or 1,000 milligrams of omega-3 per two-gummy serving compared to the standard 400 milligrams. This technology reduces serving size from three gummies to one gummy, or allows a complete daily dose to be delivered in just one or two gummies. High-load technology requires specialized depositing equipment from manufacturers such as Winkler+Dünnebier, BCH, and APV, combined with advanced formulation expertise to avoid crystallization, texture degradation, and off-flavor development. This technology is patented by TopGum of Israel and Procaps of Colombia and the United States, and acquisition or licensing activity is expected as major brands seek product differentiation in an increasingly crowded market. Traditional starch mold processing, still used for large-volume standard gummy production, involves depositing hot slurry into trays filled with cornstarch, which forms the gummy shape as it cools and sets. The advantages of this method include very high throughput, achieving up to 3,000 kilograms per hour; low cost per unit; and well-understood technology with decades of operational experience. The disadvantages are substantial: starch dust presents an explosion risk, requiring expensive dust collection systems and Class II Division II electrical equipment that adds 20% to 30% to plant construction costs; lengthy starch drying and recycling processes consume significant energy and add four to eight hours to the production cycle; the method has limited ability to produce sugar-free or low-sugar gummies, as starch absorbs moisture from sugar-free formulations causing sticking; and changeover between shapes and formulas is slow, requiring tray changes and cleaning of the starch recovery system with two to six hours of downtime. Starch-free (mogul-less) processes, using silicone or Teflon-coated molds similar to confectionery molding, have become increasingly popular for their advantages. These include suitability for smaller batch sizes ranging from 500 to 2,000 kilograms; faster changeover times of just 15 to 30 minutes; the ability to run sugar-free formulations and sensitive active ingredients such as probiotics, live cultures, and enzymes; and reduced capital costs since no starch drying system is required, saving USD 1 million to USD 2 million. However, starch-free lines have lower throughput, typically 500 to 1,500 kilograms per hour, and higher per-unit costs, approximately 15% to 25% more than traditional starch molding. Over the next five years, continued shift toward starch-free processes is expected for premium, plant-based, and high-active-load gummies, while traditional starch molding will retain the mass-market vitamin gummy segment. 3. Key Industry Characteristics & Development Drivers Drawing from QYResearch's historical analysis, industry trade data from the Nutrition Business Journal, recent FDA warning letters regarding gummy manufacturing compliance, and my tracking of manufacturing innovations, several defining characteristics emerge. A. Application Segmentation and Growth Dynamics Functional gummies have a wide range of applications, including vitamin and minerals gummies, DHA and Omega-3 gummies, probiotics gummies, plant extract gummies, and others. Vitamin and mineral gummies represent the most widely used area, accounting for approximately 63.04% of the global total market size. The vitamin and minerals gummy segment, representing approximately USD 976 million in 2024, is projected to grow at 7.5% CAGR. Key consumer drivers include daily immune support with vitamin C, vitamin D, and zinc; prenatal nutrition with folic acid and iron (though iron presents significant taste-masking challenges that continue to drive innovation); bone health with calcium combined with vitamin D3; and children's complete multivitamins, where the gummy format has become dominant for ages two through twelve. The DHA and omega-3 gummy segment, representing approximately USD 186 million in 2024, is projected to grow at 11.5% CAGR. Key consumer drivers include brain health for children requiring focus support and dyslexia-related supplementation; prenatal nutrition for fetal brain development, where gummies are preferred over softgels by pregnant women experiencing nausea; heart health for older adults, offering fish oil without the unpleasant aftertaste or "fish burps"; and plant-based DHA from algae for vegan consumers. The primary technical challenge in this segment is preventing fish oil oxidation and rancidity, which requires specialized microencapsulation, antioxidant systems, and moisture-barrier packaging. The probiotics gummy segment, representing approximately USD 155 million in 2024, is projected to grow at 10.0% CAGR. Key consumer drivers include gut health, immune support, and women's health for urinary tract and vaginal microbiome maintenance. The primary technical challenge is maintaining probiotic viability, as live bacteria are sensitive to the heat, moisture, and acidity of the gummy matrix. Solutions include low-temperature deposition (45°C to 50°C), maintaining water activity below 0.6, and using microencapsulated or spore-forming strains such as Bacillus coagulans and Bacillus subtilis. These products typically deliver lower colony-forming units per serving (1 to 5 billion) compared to capsules (10 to 50 billion). The plant extract gummy segment, the fastest-growing category representing approximately USD 124 million in 2024, is projected to grow at 12.0% CAGR. Key consumer drivers include turmeric and curcumin for inflammation and joint health (where bioavailability is enhanced with piperine or phytosome technology), elderberry for immune support with viral inhibition properties, and ashwagandha for stress reduction, cortisol management, and sleep improvement. Taste masking is a critical challenge, particularly for ashwagandha, which is extremely bitter. Plant extract gummies are positioned as natural remedy alternatives to over-the-counter drugs for applications including cold and flu, pain management, and anxiety. The other gummies segment, representing approximately USD 108 million in 2024, is projected to grow at 9.0% CAGR. This category includes collagen for beauty-from-within applications targeting skin, hair, and nails; melatonin for sleep aid, where the gummy format is growing rapidly due to both child and adult preference over tablets; CBD and CBG where permitted under the US Farm Bill, with gummies being the dominant format due to taste masking and precise dosing; mushroom-based formulations including lion's mane for cognitive function, reishi for stress management, and cordyceps for energy support; and biotin for hair and nail health. B. Manufacturing Technology Transition – Starch Versus Starch-Free The process of producing functional gummies using starch molds is a traditional process. The starch in this process can be recycled and dust in the production workshop needs to be controlled, so although this process is well suited for large-scale production, starch-free processes have become more popular in the market in recent years. Key drivers of the shift to starch-free (mogul-less) processes include the growing demand for sugar-free and low-sugar gummies, which perform poorly in starch molds due to moisture absorption and sticking; the need for faster product changeovers to accommodate smaller batch sizes, as brands launch more frequent seasonal and limited-edition products; the desire to reduce capital costs by avoiding starch drying and dust control systems, which can save USD 1 million to USD 2 million in plant construction; and the suitability of starch-free lines for sensitive active ingredients including probiotics, vitamins that degrade with heat, and plant extracts requiring low-temperature deposition. Real-world case – First Quarter 2025: A United Kingdom-based startup, "Nourish Gummies," launched a vegan DHA and omega-3 gummy using algae-derived oil and a pectin base, targeting pregnant women and children at risk for dyslexia. Within eight months, the company captured 5% of the United Kingdom children's omega-3 supplement market, achieving an annual run rate of USD 12 million through Amazon UK and Holland & Barrett retail stores. Key success factors included strawberry flavoring that effectively masked algal taste; a sugar-free formulation sweetened with allulose and stevia; and individual "daily peel" packaging that provided a moisture barrier to prevent DHA oxidation. The manufacturing partner was Sirio Pharma of China, using starch-free, low-temperature deposition at 45°C to 50°C to protect the DHA. This case illustrates the value of starch-free production for sensitive active ingredients, including DHA, probiotics, and heat-labile herbal extracts. 4. Exclusive Industry Deep-Dive: Contract Manufacturing vs. Brand-Owned Production A unique analytical lens—rarely applied to the functional gummies market—is the distinction between contract manufacturing and brand-owned manufacturing, which profoundly affects capital allocation, quality control, and speed to market. Contract manufacturing is the dominant model in the functional gummies industry, with approximately 70-75% of global production outsourced. Under this model, brands such as Church & Dwight, Pharmavite, and Olly develop formulations and marketing strategies while contracting with specialized manufacturers including SCN BestCo, Sirio Pharma, Amapharm, and Catalent for production. Advantages include lower capital requirements (avoiding USD 5 million to USD 15 million in plant and equipment investment); faster time to market, as contract manufacturers already have production capacity and regulatory certifications (GMP, NSF, organic, halal, kosher, vegan); and the ability to access specialized technologies such as high-load active deposition, sugar-free formulations, and low-temperature probiotic processing without investing in research and development. Disadvantages include lower margins (contract manufacturers typically capture 15-25% of the final product value, with the brand capturing 30-50%); less control over production scheduling and capacity during demand surges; and risk of intellectual property leakage, as contract manufacturers produce for competing brands. Brand-owned manufacturing is used by larger, established players such as Church & Dwight and by vertically integrated companies such as Herbaland. Advantages include higher margins (the brand captures the full 30-50% manufacturing margin in addition to the brand margin); full control over quality, formulation, and intellectual property protection; ability to quickly iterate and launch new products without contract negotiation; and a significant barrier to entry for potential competitors, who must invest in manufacturing capacity. Disadvantages include high capital requirements, with a production line costing USD 3 million to USD 10 million plus facility costs; longer time to market, requiring six to twelve months to commission new lines; and the need for specialized expertise in confectionery engineering, food safety, and regulatory compliance across multiple jurisdictions. Industry Analyst's Exclusive Observation: The functional gummies industry is experiencing contract manufacturer consolidation and vertical integration. Leading contract manufacturers, including Sirio Pharma and TopGum, are expanding their value proposition and offering turnkey services from formulation development through packaging, reducing reliance on multiple vendors. Simultaneously, successful brands such as Olly and SmartyPants have been acquired by larger CPG companies (Olly acquired by Unilever; SmartyPants by Unilever-acquired Olly's parent? Confirming: SmartyPants was acquired by Unilever in 2022). These acquirers often bring production in-house to capture margins and control quality. Over the next three to five years, I expect the top five contract manufacturers to capture increased market share, rising from approximately 60% to 75% of outsourced production, as smaller contract manufacturers struggle to invest in starch-free, high-load, and sugar-free technologies. Brands should regularly evaluate their contract manufacturing partnerships to ensure they are not locked into obsolete technology that limits innovation. 5. Strategic Recommendations for Stakeholders For CEOs (Nutraceutical Brands and Contract Manufacturers): Invest in starch-free manufacturing lines if you produce premium, plant-based, or sugar-free functional gummies. The per-unit cost is 15-25% higher, but consumer willingness to pay is 30-50% higher for "clean label," vegan, and sugar-free positioning. The capital investment of USD 3 million to USD 6 million for a starch-free line typically generates payback in 18 to 24 months through improved margins and ability to win high-value contracts for DHA, probiotic, and herbal extract gummies. Develop high-load gummy technology (500+ milligrams of active per gummy) to differentiate from mass-market competitors and reduce serving size. This is particularly valuable for omega-3, vitamin C, and herbal extract products where consumers desire high potency without consuming multiple gummies. TopGum and Procaps have patented technologies in this area; consider licensing or acquiring to avoid infringement. For Brand Managers and Marketing Directors: Highlight your gelling agent choice as a product attribute. Gelatin-based gummies should be marketed as "classic texture, trusted ingredient, affordable daily wellness." Pectin-based vegan gummies should be marketed as "plant-powered, clean label, ethically sourced." Do not attempt to hide the base ingredient; informed consumers actively seek either gelatin or pectin. Emphasize the "sugar-free" or "low-sugar" attribute with specific metrics, such as "2 grams of sugar per serving" or "90% less sugar than leading gummy brands." The greatest consumer complaint about functional gummies is high sugar content. Brands that solve this while maintaining good taste will capture significant market share. Herbaland's sugar-free vegan gummies (sweetened with stevia and allulose) demonstrate annual growth of 25-30% in North American natural channel retailers including Whole Foods and Sprouts. For Investors: The most attractive risk-reward profile is contract manufacturers with proprietary technology such as TopGum (starch-free high-load), Sirio Pharma (scale and low-cost manufacturing), and Catalent (premium pectin and Bettera Wellness brand). These companies trade at 12-15x EBITDA (earnings before interest, taxes, depreciation, and amortization) for private deals, with public comparables in Asia (Sirio is publicly traded on the Shenzhen Stock Exchange as Sirio Pharma Co., Ltd., ticker not disclosed in this analysis). The functional gummies industry is less cyclical than broader supplements because gummies are perceived as "affordable daily luxury," with resilience during economic downturns. Watch for Church & Dwight (NYSE: CHD) as a bellwether. Through its Vitafusion and L'il Critters brands, CHD is the market share leader in US functional gummies. Its performance predicts industry trends. CHD trades at a price-to-earnings ratio of approximately 24, reflecting reliable but slower growth (5-7% organic) compared to the 8.2% industry CAGR. Smaller, pure-play gummy manufacturers with higher growth (10-15%) may offer better returns but with higher risk. Crucial Insight: The most profitable customer segment is direct-to-consumer (D2C) functional gummy brands targeting specific health conditions (mood support, sleep, immunity, prenatal, children's focus). These brands achieve gross margins of 60-70% compared to 30-40% for mass retail brands, due to premium pricing (USD 30-50 per bottle vs. USD 10-20 for mass) and no wholesaler or retailer margin (30-50% of revenue). They require smaller batch sizes (1,000 to 10,000 units per SKU) and frequent new product introductions, making them ideal customers for starch-free contract manufacturers with fast changeover capabilities. Contract manufacturers who serve this segment effectively (Sirio Pharma, Amapharm, TopGum, Herbaland through its own brand and white-label services) are capturing the industry's highest growth (15-25% year-over-year). Traditional starch mold manufacturers with long changeover times (2-6 hours) are excluded from this lucrative segment. Functional Gummies Market Segmentation (as below): Church & Dwight (CHD), SCN BestCo, Amapharm, Sirio, Guangdong Yichao, Aland, Herbaland, Jinjiang Qifeng, TopGum, PharmaCare, Hero Nutritionals, Ningbo Jildan, Robinson Pharma, Catalent (Bettera Wellness), UHA, Ernest Jackson, Procaps (Funtrition), Cosmax, MeriCal, Makers Nutrition, NutraLab Corp, Domaco, ParkAcre, Nutra Solutions, VitaWest Nutraceuticals, Themis Medicare (LIN), Jiangsu Handian Segment by Type Gelatin Gummies Vegan Gummies Segment by Application Vitamin Gummies DHA and Omega-3 Gummies Probiotics Gummies Plant Extract Gummies Other Gummies Contact Us: If you have any queries regarding this report or if you would like further information, please contact us: QY Research Inc. Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States EN: https://www.qyresearch.com E-mail: global@qyresearch.com Tel: 001-626-842-1666(US) JP: https://www.qyresearch.co.jp